Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/1998
04/01/1998EP0832057A1 Diaromatic propynyl or dienyl compounds
04/01/1998EP0831906A1 Treatment of t cell mediated autoimmune disorders
04/01/1998EP0831902A1 Muscle trophic factor
04/01/1998EP0831881A1 Method for increasing hdl cholesterol level
04/01/1998EP0831864A1 Processed ginseng having enhanced pharmacological effect
04/01/1998EP0831857A2 Phosphate-binding polymers for oral administration
04/01/1998EP0831818A2 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
04/01/1998EP0831817A1 Antigen-processing cell-targeted conjugates
04/01/1998EP0831769A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
04/01/1998EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis
04/01/1998CN1177927A Extracts of shark cartilage, process of production and uses thereof
03/1998
03/31/1998US5734077 Antilipemic agents, anticholesterol agents, treatment of diabetes and atherosclerosis
03/31/1998US5733931 Cyclohexanediurea derivative and process for its production
03/31/1998US5733923 Secretory pancreatic phospholipase a2
03/31/1998US5733897 Imidobisphosphoric acids, and use therefor
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/27/1998CA2214922A1 Benzothiophene compounds, compositions, and methods
03/26/1998WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011909A1 Use of proteins as agents against autoimmune diseases
03/26/1998WO1998011886A1 Use of inhibitors of retinoic acid activity for wound healing
03/26/1998WO1998011884A1 Use of sibutramine analogues to prevent the development of diabetes
03/26/1998WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998CA2266346A1 Use of proteins as agents against autoimmune diseases
03/26/1998CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2236309A1 Use of inhibitors of retinoic acid activity for wound healing
03/26/1998CA2215856A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods
03/26/1998CA2214935A1 Benzofluorene compounds, intermediates, compositions, and methods
03/26/1998CA2214931A1 Tetrahydrobenzo-a-fluorene compounds and method of use
03/26/1998CA2214929A1 Naphthofluorene compounds, intermediates, compositions and methods
03/26/1998CA2214196A1 Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
03/26/1998CA2214176A1 Dihydrobenzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
03/25/1998EP0831089A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/25/1998EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
03/25/1998EP0830390A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
03/25/1998EP0830377A1 Glucagon-like peptide-2 and its therapeutic use
03/25/1998EP0830348A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
03/25/1998EP0830138A1 Use of fibroblast growth factors to stimulate bone growth
03/25/1998EP0624163B1 Cyclic calcitonin derivatives and method for their production
03/25/1998CN1177343A Cell adhesion inhibitors
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1037842C Thiazole or imidazole derivatives as maillard reaction inhibitors
03/24/1998US5731455 Alkyl 2-alkylacylacrylate chemical intermediate; anticholesterol agents
03/24/1998US5731351 Antiarrhythmia agents
03/24/1998US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/24/1998US5731344 Diabetes, atherosclerosis, arteriosclerosis; inhibitors of advanced glycosylation endproducts
03/24/1998US5731340 Dietetics; antidiabetic agents
03/24/1998US5731337 Conformationally rigid bicycle and adamantane derivatives useful as α2
03/24/1998US5731319 Antiallergens; antihistamines
03/24/1998US5731313 Use of anthracyclinone derivatives in amyloidosis
03/24/1998US5731312 Administering mixture of dopamine antagonist and prolactin inhibitor
03/24/1998US5731299 Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
03/24/1998US5731290 Method of improving the immune response
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998CA2214919A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/19/1998WO1998011435A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011116A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2264938A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998CA2264829A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/19/1998CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/18/1998EP0829541A2 Osmo-controlled fermentation process for the preparation of acarbose
03/18/1998EP0829470A1 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments
03/18/1998EP0829261A2 Composition comprising isoflavone or derivatives thereof for promoting fat-degradation in fat-cells
03/18/1998EP0828851A2 Tripeptidylpeptidase inhibitors
03/18/1998EP0828758A1 Chimeric fatty body-pro-grf analogs with increased biological potency
03/18/1998EP0828754A1 Dipeptides which promote release of growth hormone
03/18/1998EP0828746A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
03/18/1998EP0828712A1 Beta-adrenergic agonists
03/18/1998EP0828505A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
03/18/1998EP0828503A1 Treatment for inhibiting the progression of autoimmune disease
03/18/1998EP0828497A1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives
03/18/1998EP0828496A1 Use of alendronate for the prevention of osteoporosis
03/18/1998EP0828484A1 Use of aryl substituted cyclobutyl alkyl amines for the treatment of obesity
03/18/1998EP0828481A1 Oral dosage composition for intestinal delivery and method of use of the same
03/18/1998EP0828434A1 Fat based food products
03/18/1998CN1176646A CCK or gastrin modulating 5 -heterocyclic-1, 5-benzodiazepines
03/18/1998CN1176640A Inhibitors of microsomal triglyceride transfer protein and mothed
03/18/1998CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
03/18/1998CN1176248A Restricted 9-CIS-retinoids
03/17/1998US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
03/17/1998US5728829 Multistage reaction of n-protected benzotriazolyl glycine derivative with aminoketone, then reaction with ammonia and acid catalyzed cyclization
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728739 Ligands with affinity for retinoic acid receptors in synergistic combination with a fatty acid, treatment of diabetes, cardiovascular disease, atherosclerosis
03/17/1998US5728704 Substituted pyridmidines for control of diabetic complications
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998US5728678 Method and composition for providing nutrition to a renal failure patient
03/17/1998CA1339740C Alpha-glucosidase inhibitors
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 1298